Earlier this month I went to Vienna for the 57th session of the Commission on Narcotic Drugs (CND), part of the United Nations Office on Drugs and Crime (UNODC). There I chaired a working group that presented a set of recommendations to the CND concerning the most appropriate, scientifically informed way to approach the problem of substance use disorders: as a medical, not a legal, issue.
Presents research-based principles of adolescent substance use disorder treatment; covers treatment for a variety of drugs including, illicit and prescription drugs, alcohol, and tobacco; presents settings and evidence-based approaches unique to treating adolescents.
Offers educational tools to assist in the prevention, screening, evaluation, and referral to treatment of adolescents with or at risk for substance use disorders. Includes a video and facilitator's guide.
The epidemic of prescription opioid abuse in this country is linked partly to the dramatic rise in prescriptions for these medicines over the last two decades, as well as the fact that many clinicians are inadequately trained to safely treat pain in their patients. Most medical schools only offer a few hours of instruction in safe prescribing of opioids for pain management. A recent review showed that only 3% of U.S. medical schools offer integrated pain management courses.
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, will present a special research track at the American Psychiatric Association’s (APA’s) 166th annual meeting in San Francisco from May 18 to 22.